Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Recommendations

Info

10. Sedatives/Hypnotics and Benzodiazepines 241(Eds.), Principles of addiction medicine (3rd ed., pp. 977–985). Chevy Chase, MD:American Society of Addiction Medicine.Medical Economics Data Production. (2003). Physicians’ desk reference. Montvale, NJ:Author.Mellinger, G. D., & Balter, M. B. (1981). Prevalence and patterns of use of psychotherapeuticdrugs: Results from a 1979 national survey of American adults. In G.Tognoni, C. Bellantuono, & M. Lader (Eds.), Epidemiological impact of psycho-tropicdrugs (pp. 117–135). Amsterdam: Elsevier.Mendelson, W. B., Roth, T., Casella, J., Roehrs, T., Walsh, J., Woods, J. H., et al.(2001). Report on a conference: The treatment of chronic insomnia: Drug indication,chronic use and abuse liability. Paper presented at the NCDEU meeting, Phoenix,AZ.Noyes, R., Garvey, M. J., Cook, B. L., & Perry, P. J. (1988). Benzodiazepine withdrawal:A review of the evidence. J Clin Psychiatry, 49, 382–389.Rickels, K., Schweizer, E., Csanalosi, I., Case, G. W., & Chung, H. (1988). Long-termtreatment of anxiety and risk of withdrawal. Arch Gen Psychiatry, 45, 444–450.Ross, J. (1994). Triumph over fear: A book of help and hope for people with anxiety, panicattacks, and phobias. New York: Bantam.Sattar, S. P., & Bhatia, S. (2003). Benzodiazepines for substance abusers. Curr Psychiatry,l2(5), 25–34.Savage, S. R. (2003). Principles of pain management in the addicted patient. In A. W.Graham, T. K. Schultz, M. F. Mayo Smith, & R. K. Ries (Eds.), Principles of addictionmedicine (3rd ed., pp. 1405–1419). Chevy Chase, MD: American Society ofAddiction Medicine.Scharf, M. B., Mayleben, D. W., Kaffeman, M., Krall, R., & Ochs, R. (1991). Doseresponse effects of zolpidem in normal geriatric subjects. J Clin Psychiatry, 52, 77–83.Schenck, C. H., & Mahowald, M. W. (1996). Long-term, nightly benzodiazepine treatmentof injurious parasomnias and other disorders of disrupted nocturnal sleep in170 adults. Am J Med, 100, 333–337.Sellers, E. M., Ciraulo, D. A., DuPont, R. L., Griffiths, R. R., Kosten, T. R., Romach,M. K., & Woody, G. E. (1993). Alprazolam and benzodiazepine dependence. J ClinPsychiatry, 54(Suppl), 64–74.Spencer, E. D., DuPont, R. L., & DuPont, C. M. (2004). The anxiety cure for kids: Aguide for parents. New York: Wiley.Stahl, S. M. (2003). At long last, long-lasting psychiatric medications: An overview ofcontrolled-released technologies. J Clin Psychiatry, 64, 4.Sussman, N., & Stein, D. J. (2002). Pharmacotherapy for generalized anxiety disorder.In D. J. Stein & E. Hollander (Eds.), Textbook of anxiety disorders (pp. 135–141).Washington, DC: American Psychiatric Press.Tyrer, P., Rutherford, D., & Huggett, D. (1981). Benzodiazepine withdrawal symptomsand propranolol. Lancet, 1, 520–522.U.S. Department of Health and Human Services. (2001, March). Monitoring theFuture—overview of key findings (NIH Publication No. 02-5105). Rockville, MD:National Institutes of Health, National Institute on Drug Abuse.U.S. Department of Health and Human Services. (2002). Results from the 2001 NationalHousehold Survey on Drug Abuse (DHHS Publication No. SMA 02-3758). Rock-
242 III. SUBSTANCES OF ABUSEville, MD: Substance Abuse and Mental Health Services Administration, Office ofApplied Studies.Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avom, J. (2001). Hazardousbenzodiazepine regimes in the elderly: Effects of half-life, dosage, and duration onrisk of hip fracture. Am J Psychiatry, 158, 892–898.Wesson, D. R., Smith, D. E., & Ling, W. (2003). Pharmacologic interventions forbenzodiazepine and other sedative–hypnotic addiction. In A. W. Graham, T. K.Schultz, M. F. Mayo Smith, & R. K. Ries (Eds.), Principles of addiction medicine (3rded., pp. 721–735). Chevy Chase, MD: American Society of Addiction Medicine.World Health Organization. (1988). The use of essential drugs: Third report of the WorldHealth Organization expert committee (WHO Technical Report Series No. 770).Geneva: Author.
Page 2:
CLINICAL TEXTBOOK OF ADDICTIVE DISO
Page 5 and 6:
© 2005 The Guilford PressA Divisio
Page 7 and 8:
viAbout the EditorsMedical College.
Page 9 and 10:
viiiContributorsStephen L. Dilts, M
Page 11 and 12:
xContributorsRussell K. Portenoy, M
Page 13 and 14:
xiiPrefaceof alcohol in the 2002 su
Page 15 and 16:
xivPrefaceResearch (1) on health sy
Page 18 and 19:
ContentsPART I. FOUNDATIONS OF ADDI
Page 20:
ContentsxixPART V. TREATMENTS FOR A
Page 24 and 25:
CHAPTER 1The Neurobiologyof Substan
Page 26 and 27:
1. The Neurobiology of Substance De
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
2. Historical and Social Context 17
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 55 and 56:
34 I. FOUNDATIONS OF ADDICTIONThomp
Page 58 and 59:
CHAPTER 3Psychological Evaluationof
Page 60 and 61:
3. Psychological Evaluation 39sever
Page 62 and 63:
3. Psychological Evaluation 41neuro
Page 64 and 65:
3. Psychological Evaluation 43In su
Page 66 and 67:
3. Psychological Evaluation 45subst
Page 68 and 69:
3. Psychological Evaluation 47is im
Page 70 and 71:
3. Psychological Evaluation 49Self-
Page 72 and 73:
3. Psychological Evaluation 51decis
Page 74 and 75:
3. Psychological Evaluation 53Socia
Page 76 and 77:
3. Psychological Evaluation 55Behav
Page 78 and 79:
3. Psychological Evaluation 57socia
Page 80 and 81:
3. Psychological Evaluation 59Lezak
Page 82 and 83:
3. Psychological Evaluation 61Tarte
Page 84 and 85:
CHAPTER 4Laboratory Testingfor Subs
Page 86 and 87:
4. Laboratory Testing 65stance. It
Page 88 and 89:
4. Laboratory Testing 67tive in lab
Page 90 and 91:
4. Laboratory Testing 69Agency (USA
Page 92:
4. Laboratory Testing 71CONCLUSIOND
Page 96 and 97:
CHAPTER 5AlcoholEDGAR P. NACEAlcoho
Page 98 and 99:
5. Alcohol 77withdrawal symptoms, b
Page 100 and 101:
5. Alcohol 79Drug Abuse-DependenceA
Page 102 and 103:
5. Alcohol 81symptoms as schizophre
Page 104 and 105:
5. Alcohol 83show low incidences of
Page 106 and 107:
5. Alcohol 85the rate of eliminatio
Page 108 and 109:
5. Alcohol 87nisms. The symptoms of
Page 110 and 111:
5. Alcohol 89individual with a hist
Page 112 and 113:
5. Alcohol 91The small intestine sh
Page 114 and 115:
5. Alcohol 93alcohol’s effect of
Page 116 and 117:
5. Alcohol 95Bone marrow recovery w
Page 118 and 119:
5. Alcohol 97Female breast cancer s
Page 120 and 121:
5. Alcohol 99tion and management. P
Page 122 and 123:
5. Alcohol 101nervosa and alcohol u
Page 124 and 125:
5. Alcohol 103for alcohol-related p
Page 126 and 127:
CHAPTER 6TobaccoNORMAN HYMOWITZHIST
Page 128 and 129:
6. Tobacco 107geon General’s Advi
Page 130 and 131:
6. Tobacco 109Smokers are wrong abo
Page 132 and 133:
6. Tobacco 111significant substance
Page 134 and 135:
6. Tobacco 113exacerbate existing i
Page 136 and 137:
6. Tobacco 115Substance use, in gen
Page 138 and 139:
6. Tobacco 117cological aids (Fager
Page 140 and 141:
6. Tobacco 119ciently nonirritating
Page 142 and 143:
6. Tobacco 121particular reinforcin
Page 144 and 145:
6. Tobacco 123The results of a smal
Page 146 and 147:
6. Tobacco 125proaches to smoking c
Page 148 and 149:
6. Tobacco 127smoking, and to smoke
Page 150 and 151:
6. Tobacco 129.02) and the 300-mg g
Page 152 and 153:
6. Tobacco 131cholinergic bronchodi
Page 154 and 155:
6. Tobacco 133Green, D.E. (1980). B
Page 156 and 157:
6. Tobacco 135Orleans, C. T. (1993)
Page 158 and 159:
6. Tobacco 137Monograph No. 17, DHE
Page 160 and 161:
7. Opioids 139DEFINITIONSThe opioid
Page 162 and 163:
7. Opioids 141sion of control chara
Page 164 and 165:
TABLE 7.2. Opioid Withdrawal7. Opio
Page 166 and 167:
7. Opioids 145The concept of tolera
Page 168 and 169:
7. Opioids 147der with water, heat
Page 170 and 171:
7. Opioids 149overdose in a pregnan
Page 172 and 173:
7. Opioids 151who may inject from f
Page 174 and 175:
7. Opioids 153more methadone, possi
Page 176 and 177:
7. Opioids 155Bickel, W. K., Stitze
Page 178 and 179:
Marijuana, Hallucinogens,and Club D
Page 180 and 181:
8. Marijuana, Hallucinogens, and Cl
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
9. Cocaine and Stimulants 185among
Page 208 and 209:
9. Cocaine and Stimulants 187Cocain
Page 210 and 211:
9. Cocaine and Stimulants 189ited,
Page 212 and 213: 9. Cocaine and Stimulants 191postsy
Page 214 and 215: 9. Cocaine and Stimulants 193herita
Page 216 and 217: 9. Cocaine and Stimulants 195Kleber
Page 218 and 219: 9. Cocaine and Stimulants 197When c
Page 220 and 221: 9. Cocaine and Stimulants 199OBSTET
Page 222 and 223: 9. Cocaine and Stimulants 201guide
Page 224 and 225: 9. Cocaine and Stimulants 203Cognit
Page 226 and 227: 9. Cocaine and Stimulants 205tity i
Page 228 and 229: 9. Cocaine and Stimulants 207purifi
Page 230 and 231: 9. Cocaine and Stimulants 209ence n
Page 232 and 233: 9. Cocaine and Stimulants 211Brady,
Page 234 and 235: 9. Cocaine and Stimulants 213others
Page 236 and 237: 9. Cocaine and Stimulants 215Martin
Page 238 and 239: 9. Cocaine and Stimulants 217DHHS P
Page 240 and 241: Sedatives/Hypnoticsand Benzodiazepi
Page 242 and 243: 10. Sedatives/Hypnotics and Benzodi
Page 248 and 249: TABLE 10.1. Pharmacological Charact
Page 264: PART IVSPECIAL POPULATIONS
Page 267 and 268: 246 IV. SPECIAL POPULATIONSThis con
Page 269 and 270: 248 IV. SPECIAL POPULATIONSin patie
Page 271 and 272: 250 IV. SPECIAL POPULATIONSdisorder
Page 273 and 274: 252 IV. SPECIAL POPULATIONSsample o
Page 275 and 276: 254 IV. SPECIAL POPULATIONSAntisoci
Page 277 and 278: 256 IV. SPECIAL POPULATIONS(Cloning
Page 279 and 280: 258 IV. SPECIAL POPULATIONSdrug is
Page 281 and 282: 260 IV. SPECIAL POPULATIONSneous us
Page 283 and 284: 262 IV. SPECIAL POPULATIONSamine an
Page 285 and 286: 264 IV. SPECIAL POPULATIONSor bupre
Page 287 and 288: 266 IV. SPECIAL POPULATIONSsonality
Page 289 and 290: 268 IV. SPECIAL POPULATIONS(2001).
Page 291 and 292: 270 IV. SPECIAL POPULATIONSTómasso
Page 293 and 294: 272 IV. SPECIAL POPULATIONSAddition
Page 295 and 296: 274 IV. SPECIAL POPULATIONStreatmen
Page 297 and 298: 276 IV. SPECIAL POPULATIONSOther Th
Page 299 and 300: 278 IV. SPECIAL POPULATIONSDIAGNOSI
Page 301 and 302: 280 IV. SPECIAL POPULATIONStransfer
Page 303 and 304: 282 IV. SPECIAL POPULATIONSSpecific
Page 305 and 306: 284 IV. SPECIAL POPULATIONSattendin
Page 307 and 308: 286 IV. SPECIAL POPULATIONSPHARMACO
Page 309 and 310: 288 IV. SPECIAL POPULATIONSdiagnose
Page 311 and 312: 290 IV. SPECIAL POPULATIONSimproved
Page 313 and 314:
292 IV. SPECIAL POPULATIONSwith nov
Page 315 and 316:
294 IV. SPECIAL POPULATIONSand abus
Page 317 and 318:
296 IV. SPECIAL POPULATIONSpatients
Page 319 and 320:
298 IV. SPECIAL POPULATIONSMahler,
Page 321 and 322:
300 IV. SPECIAL POPULATIONSPowell,
Page 323 and 324:
302 IV. SPECIAL POPULATIONSWeiss, R
Page 325 and 326:
304 IV. SPECIAL POPULATIONSCORE FEA
Page 327 and 328:
306 IV. SPECIAL POPULATIONSThe asso
Page 329 and 330:
308 IV. SPECIAL POPULATIONSefficacy
Page 331 and 332:
TABLE 13.2. Double-Blind, Placebo-C
Page 333 and 334:
312 IV. SPECIAL POPULATIONSreceivin
Page 335 and 336:
314 IV. SPECIAL POPULATIONSLike ind
Page 337 and 338:
316 IV. SPECIAL POPULATIONSmomentar
Page 339 and 340:
318 IV. SPECIAL POPULATIONSChambers
Page 341 and 342:
320 IV. SPECIAL POPULATIONSorders.
Page 343 and 344:
322 IV. SPECIAL POPULATIONSican wom
Page 345 and 346:
324 IV. SPECIAL POPULATIONSamounts
Page 347 and 348:
326 IV. SPECIAL POPULATIONSLiteratu
Page 349 and 350:
328 IV. SPECIAL POPULATIONStrol and
Page 351 and 352:
330 IV. SPECIAL POPULATIONS& Fein,
Page 353 and 354:
332 IV. SPECIAL POPULATIONSAsian pr
Page 355 and 356:
334 IV. SPECIAL POPULATIONSBaker, F
Page 357 and 358:
336 IV. SPECIAL POPULATIONSGraves,
Page 359 and 360:
338 IV. SPECIAL POPULATIONSDifferen
Page 361 and 362:
CHAPTER 15Addictions in the Workpla
Page 363 and 364:
342 IV. SPECIAL POPULATIONSOrganiza
Page 365 and 366:
344 IV. SPECIAL POPULATIONSStimulan
Page 367 and 368:
346 IV. SPECIAL POPULATIONSemployer
Page 369 and 370:
348 IV. SPECIAL POPULATIONSshould b
Page 371 and 372:
350 IV. SPECIAL POPULATIONSstances,
Page 373 and 374:
352 IV. SPECIAL POPULATIONSbe halte
Page 375 and 376:
CHAPTER 16Addiction and the LawAVRA
Page 377 and 378:
356 IV. SPECIAL POPULATIONSobjected
Page 379 and 380:
358 IV. SPECIAL POPULATIONSOver tim
Page 381 and 382:
360 IV. SPECIAL POPULATIONSDisabili
Page 383 and 384:
362 IV. SPECIAL POPULATIONSdrawal f
Page 385 and 386:
364 IV. SPECIAL POPULATIONSStates h
Page 387 and 388:
366 IV. SPECIAL POPULATIONSMcClella
Page 389 and 390:
368 IV. SPECIAL POPULATIONSThe expa
Page 391 and 392:
370 IV. SPECIAL POPULATIONSThere co
Page 393 and 394:
372 IV. SPECIAL POPULATIONSTABLE 17
Page 395 and 396:
374 IV. SPECIAL POPULATIONScommon m
Page 397 and 398:
376 IV. SPECIAL POPULATIONSstand th
Page 399 and 400:
378 IV. SPECIAL POPULATIONSapproach
Page 401 and 402:
380 IV. SPECIAL POPULATIONS1. What
Page 403 and 404:
TABLE 17.5. Opioid AsnalgesicsEquia
Page 405 and 406:
384 IV. SPECIAL POPULATIONSadminist
Page 407 and 408:
386 IV. SPECIAL POPULATIONSas methy
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
392 IV. SPECIAL POPULATIONSArner, S
Page 415 and 416:
394 IV. SPECIAL POPULATIONSPassik,
Page 417 and 418:
CHAPTER 18Alcoholism and Substance
Page 419 and 420:
398 IV. SPECIAL POPULATIONSdrug eff
Page 421 and 422:
400 IV. SPECIAL POPULATIONSI (Zimbe
Page 423 and 424:
402 IV. SPECIAL POPULATIONSAlcohol-
Page 425 and 426:
404 IV. SPECIAL POPULATIONSStaffing
Page 427 and 428:
406 IV. SPECIAL POPULATIONSLocation
Page 429 and 430:
408 IV. SPECIAL POPULATIONSREFERENC
Page 431 and 432:
410 IV. SPECIAL POPULATIONSSurock,
Page 433 and 434:
412 IV. SPECIAL POPULATIONSfueling
Page 435 and 436:
414 IV. SPECIAL POPULATIONSLipton &
Page 437 and 438:
416 IV. SPECIAL POPULATIONSCo-abuse
Page 439 and 440:
418 IV. SPECIAL POPULATIONSsion. We
Page 441 and 442:
420 IV. SPECIAL POPULATIONSand the
Page 443 and 444:
422 IV. SPECIAL POPULATIONSthe immu
Page 445 and 446:
424 IV. SPECIAL POPULATIONSothers w
Page 447 and 448:
426 IV. SPECIAL POPULATIONSfuture p
Page 449 and 450:
428 IV. SPECIAL POPULATIONSand sex-
Page 451 and 452:
430 IV. SPECIAL POPULATIONSCole, S.
Page 453 and 454:
432 IV. SPECIAL POPULATIONSto reten
Page 455 and 456:
434 IV. SPECIAL POPULATIONSSheridan
Page 457 and 458:
436 IV. SPECIAL POPULATIONSDrug use
Page 459 and 460:
438 IV. SPECIAL POPULATIONSthe trea
Page 461 and 462:
440 IV. SPECIAL POPULATIONSweight),
Page 463 and 464:
442 IV. SPECIAL POPULATIONSin misca
Page 465 and 466:
444 IV. SPECIAL POPULATIONSdiagnose
Page 467 and 468:
446 IV. SPECIAL POPULATIONSCLINICAL
Page 469 and 470:
Page 471 and 472:
450 IV. SPECIAL POPULATIONSREFERENC
Page 473 and 474:
452 IV. SPECIAL POPULATIONSand phys
Page 476:
PART VTREATMENTS FOR ADDICTIONS
Page 479 and 480:
458 V. TREATMENTS FOR ADDICTIONSAlt
Page 481 and 482:
460 V. TREATMENTS FOR ADDICTIONSPSY
Page 483 and 484:
462 V. TREATMENTS FOR ADDICTIONSkno
Page 485 and 486:
464 V. TREATMENTS FOR ADDICTIONSThr
Page 487 and 488:
466 V. TREATMENTS FOR ADDICTIONStor
Page 489 and 490:
468 V. TREATMENTS FOR ADDICTIONSarr
Page 491 and 492:
470 V. TREATMENTS FOR ADDICTIONScon
Page 493 and 494:
472 V. TREATMENTS FOR ADDICTIONSKha
Page 495 and 496:
CHAPTER 22Cognitive TherapyJUDITH S
Page 497 and 498:
476 V. TREATMENTS FOR ADDICTIONSFIG
Page 499 and 500:
Page 501 and 502:
480 V. TREATMENTS FOR ADDICTIONSand
Page 503 and 504:
482 V. TREATMENTS FOR ADDICTIONSbet
Page 505 and 506:
Page 507 and 508:
486 V. TREATMENTS FOR ADDICTIONSAdv
Page 509 and 510:
488 V. TREATMENTS FOR ADDICTIONSThr
Page 511 and 512:
490 V. TREATMENTS FOR ADDICTIONSthe
Page 513 and 514:
492 V. TREATMENTS FOR ADDICTIONSIf
Page 515 and 516:
494 V. TREATMENTS FOR ADDICTIONSThe
Page 517 and 518:
496 V. TREATMENTS FOR ADDICTIONSMot
Page 519 and 520:
498 V. TREATMENTS FOR ADDICTIONSRes
Page 521 and 522:
500 V. TREATMENTS FOR ADDICTIONSLie
Page 523 and 524:
CHAPTER 23Group Therapy, Self-Help
Page 525 and 526:
504 V. TREATMENTS FOR ADDICTIONSTAB
Page 527 and 528:
506 V. TREATMENTS FOR ADDICTIONSmai
Page 529 and 530:
Page 531 and 532:
510 V. TREATMENTS FOR ADDICTIONSdri
Page 533 and 534:
Page 535 and 536:
514 V. TREATMENTS FOR ADDICTIONSavo
Page 537 and 538:
516 V. TREATMENTS FOR ADDICTIONSSel
Page 539 and 540:
518 V. TREATMENTS FOR ADDICTIONSera
Page 541 and 542:
520 V. TREATMENTS FOR ADDICTIONSins
Page 543 and 544:
522 V. TREATMENTS FOR ADDICTIONSthi
Page 545 and 546:
524 V. TREATMENTS FOR ADDICTIONSREF
Page 547 and 548:
526 V. TREATMENTS FOR ADDICTIONSfor
Page 549 and 550:
CHAPTER 24Family-Based TreatmentSta
Page 551 and 552:
530 V. TREATMENTS FOR ADDICTIONS1.
Page 553 and 554:
532 V. TREATMENTS FOR ADDICTIONSin
Page 555 and 556:
534 V. TREATMENTS FOR ADDICTIONStre
Page 557 and 558:
Page 559 and 560:
538 V. TREATMENTS FOR ADDICTIONSfir
Page 561 and 562:
540 V. TREATMENTS FOR ADDICTIONSles
Page 563 and 564:
542 V. TREATMENTS FOR ADDICTIONSove
Page 565 and 566:
544 V. TREATMENTS FOR ADDICTIONS1.
Page 567 and 568:
Page 569 and 570:
548 V. TREATMENTS FOR ADDICTIONSvs.
Page 571 and 572:
550 V. TREATMENTS FOR ADDICTIONSWit
Page 573 and 574:
Page 575 and 576:
554 V. TREATMENTS FOR ADDICTIONSBeh
Page 577 and 578:
556 V. TREATMENTS FOR ADDICTIONSO
Page 579 and 580:
558 V. TREATMENTS FOR ADDICTIONSadd
Page 581 and 582:
560 V. TREATMENTS FOR ADDICTIONSinh
Page 583 and 584:
562 V. TREATMENTS FOR ADDICTIONSabu
Page 585 and 586:
564 V. TREATMENTS FOR ADDICTIONSPar
Page 587 and 588:
566 V. TREATMENTS FOR ADDICTIONSeti
Page 589 and 590:
568 V. TREATMENTS FOR ADDICTIONSest
Page 591 and 592:
570 V. TREATMENTS FOR ADDICTIONSpro
Page 593 and 594:
572 V. TREATMENTS FOR ADDICTIONStie
Page 595 and 596:
574 V. TREATMENTS FOR ADDICTIONSmos
Page 597 and 598:
576 V. TREATMENTS FOR ADDICTIONSiss
Page 599 and 600:
578 V. TREATMENTS FOR ADDICTIONStiv
Page 601 and 602:
580 V. TREATMENTS FOR ADDICTIONSris
Page 603 and 604:
582 V. TREATMENTS FOR ADDICTIONSHen
Page 605 and 606:
584 V. TREATMENTS FOR ADDICTIONSLew
Page 607 and 608:
586 V. TREATMENTS FOR ADDICTIONSRob
Page 609 and 610:
CHAPTER 26Psychopharmacological Tre
Page 611 and 612:
590 V. TREATMENTS FOR ADDICTIONSmen
Page 613 and 614:
592 V. TREATMENTS FOR ADDICTIONS(1,
Page 615 and 616:
594 V. TREATMENTS FOR ADDICTIONSred
Page 617 and 618:
596 V. TREATMENTS FOR ADDICTIONShav
Page 619 and 620:
598 V. TREATMENTS FOR ADDICTIONSKha
Page 621 and 622:
600 V. TREATMENTS FOR ADDICTIONSSuc
Page 623 and 624:
602 V. TREATMENTS FOR ADDICTIONSuse
Page 625 and 626:
Page 627 and 628:
606 V. TREATMENTS FOR ADDICTIONScal
Page 629 and 630:
608 V. TREATMENTS FOR ADDICTIONSwit
Page 631 and 632:
610 V. TREATMENTS FOR ADDICTIONSon
Page 633 and 634:
612 V. TREATMENTS FOR ADDICTIONSMas
Page 635 and 636:
614 V. TREATMENTS FOR ADDICTIONSado
Page 637 and 638:
616 V. TREATMENTS FOR ADDICTIONSule
Page 639 and 640:
618 V. TREATMENTS FOR ADDICTIONSdia
Page 641 and 642:
Page 643 and 644:
622 V. TREATMENTS FOR ADDICTIONSmen
Page 645 and 646:
624 V. TREATMENTS FOR ADDICTIONSsta
Page 647 and 648:
626 V. TREATMENTS FOR ADDICTIONShab
Page 649 and 650:
628 V. TREATMENTS FOR ADDICTIONSadd
Page 651 and 652:
630 V. TREATMENTS FOR ADDICTIONScog
Page 653 and 654:
Page 655 and 656:
634 V. TREATMENTS FOR ADDICTIONScat
Page 657 and 658:
636 V. TREATMENTS FOR ADDICTIONSLin
Page 659 and 660:
638 V. TREATMENTS FOR ADDICTIONSBri
Page 661 and 662:
640 V. TREATMENTS FOR ADDICTIONSpat
Page 663 and 664:
642 V. TREATMENTS FOR ADDICTIONSalt
Page 665 and 666:
644 V. TREATMENTS FOR ADDICTIONSere
Page 667 and 668:
646 V. TREATMENTS FOR ADDICTIONS(Vo
Page 669 and 670:
648 V. TREATMENTS FOR ADDICTIONSres
Page 671 and 672:
650 V. TREATMENTS FOR ADDICTIONSfor
Page 673 and 674:
652 V. TREATMENTS FOR ADDICTIONSVou
Page 675 and 676:
654 V. TREATMENTS FOR ADDICTIONSto
Page 677 and 678:
656 V. TREATMENTS FOR ADDICTIONSals
Page 679 and 680:
658 V. TREATMENTS FOR ADDICTIONSGal
Page 681 and 682:
660 V. TREATMENTS FOR ADDICTIONSMoy
Page 683 and 684:
662 V. TREATMENTS FOR ADDICTIONStie
Page 685 and 686:
664 IndexAfrican Americansadolescen
Page 687 and 688:
666 IndexAsian Americans (cont.)rel
Page 689 and 690:
668 IndexCocaine use and abuse (con
Page 691 and 692:
670 IndexDepressionin adolescents,
Page 693 and 694:
672 IndexFetal alcohol syndrome, 97
Page 695 and 696:
674 IndexImpulse control disorders
Page 697 and 698:
676 IndexMethamphetamine (cont.)neu
Page 699 and 700:
678 IndexPPain managementadjuvant a
Page 701 and 702:
680 IndexPsychological assessment (
Page 703 and 704:
682 IndexSexual behaviorHIV infecti
Page 705:
684 IndexWWernicke-Korsakoff syndro
show all

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Create successful ePaper yourself

Delete template?

Save as template?